» Articles » PMID: 16864816

Age-dependent Prevalence and Clinical Features of Migraine

Overview
Journal Neurology
Specialty Neurology
Date 2006 Jul 26
PMID 16864816
Citations 79
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Available data suggest two seemingly opposite trends with regard to the natural history of migraine. Migraine prevalence decreases with age. In some individuals, migraine progresses to chronic daily headache.

Objective: To contrast the clinical features of migraine across the life span.

Methods: A validated computer-assisted telephone interview (CATI) was used to identify a population sample in three urban centers in the United States. Eligible participants were older than 18 years. The CATI covered the International Classification of Headache Disorders criteria for migraine and probable migraine (PM). Prevalence and clinical features of migraine and PM were examined by age.

Results: This sample consists of 145,335 participants. The overall prevalence of migraine was 15%, whereas the overall prevalence of PM was 14.6%. Migraine prevalence was highest between ages 30 and 39 years. In older ages, PM was more prevalent than migraine. Among those with migraine, the prevalence of unilateral and throbbing pain peaked at intermediate ages and declined after that. The prevalence of photophobia and phonophobia related to the attacks declined with ages, whereas the prevalence of aura increased. The proportion of those with 10 to 14 headache days per month also increased, from 12.5% in those ages 18 to 29 to 41.0% (odds ratio = 4.8, 95% CI = 3.9 to 7.1) in those older than 70.

Conclusion: The profile of migraine changes over the life span and suggests three nonexclusive profiles. In many, migraine remits. In some patients with migraine, attacks get less typical, resembling probable migraine instead of full migraine. In some, migraine progresses.

Citing Articles

Association between headache laterality in migraine and hemispheric distribution of white matter hyperintensities on MRI.

Sprouse Blum A, Zenger S, Nguyen A, Parra J, Stahl E, Littenberg B J Neurol. 2024; 272(1):18.

PMID: 39666216 DOI: 10.1007/s00415-024-12793-4.


Feasibility of Fish Oil Supplementation on Headache Symptoms and Blood Lipids in Migraine Patients.

Yeh E, Yang C, Lin S, Wang H Brain Behav. 2024; 14(12):e70149.

PMID: 39643480 PMC: 11624007. DOI: 10.1002/brb3.70149.


The influence of factors associated with past reproductive histories on migraines in middle-aged premenopausal women: a nationwide population-based study in Republic of Korea.

Kim S, Na S, Kim Y, Bae D, An J, Park J Front Neurol. 2024; 15:1406443.

PMID: 38915802 PMC: 11194392. DOI: 10.3389/fneur.2024.1406443.


The Association Between Shift Work and Migraine Attacks Among Healthcare Workers in the Kingdom of Saudi Arabia.

Al Maqwashi L, Sufyani A, Bichara M, Rajikhan Y, Albishri M, Hamood N Cureus. 2024; 16(1):e53315.

PMID: 38435892 PMC: 10906779. DOI: 10.7759/cureus.53315.


Combination of anti-CGRP/CGRP-R mAbs with onabotulinumtoxin A as a novel therapeutic approach for refractory chronic migraine: a retrospective study of real-world clinical evidence and a protocol for a double-blind, randomized clinical trial to....

Corasaniti M, Lawrence G, Bagetta G, Iannacchero R, Tarsitano A, Monteleone A Front Pharmacol. 2023; 14:1296577.

PMID: 38152694 PMC: 10751376. DOI: 10.3389/fphar.2023.1296577.